Summary:
Click image to enlarge
The purpose of this study is to evaluate the effectiveness and safety of an investigational compound for Major Depressive Disorder. The study consists of a 6 week outpatient study treatment period, followed by a safety follow up period. All procedures and study visits will take place at CBH Health located in Gaithersburg, MD.
Qualified Participants Must:
• Male or Female, Ages 18-75
•
Diagnosis of Major Depressive Disorder and currently experiencing a Major Depressive Episode
•
Be in good physical health as ascertained by medical history, physical examination, and clinical laboratory evaluations
•
History of bipolar disorder, schizophrenia, or schizoaffective disorder is exclusionary.
•
No seizure disorder, strokes or tumor
•
Current diagnosis of substance abuse or within past 6 months is exclusionary
•
Current sucidal ideation or a suicide attempt within the past year is exclusionary
Qualified Participants May Receive:
Compensation will be provided.